Keywords: DGC; diffuse-type gastric cancer; FDR; first-degree relative; HDGC; hereditary diffuse-type gastric cancer; SRCC; signet ring cell carcinoma;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HDGC; hereditary diffuse gastric cancer; LBC; lobular breast cancer; PTG; prophylactic total gastrectomy; SRC; signet ring cell; SRCC; signet ring cell carcinoma;
Keywords: Atoh1; Atonal homolog 1; MC; mucinous colon cancer; SRCC; signet ring cell carcinoma; GSK3; glycogen synthase kinase 3; Lgr5; Leucine-rich repeat-containing G-protein coupled receptor 5; IEC; intestinal epithelial cells; MUC2; mucin 2; TFF3; trefoil facto
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status
Keywords: AEI; allelic expression imbalance; CDH1+; CDH1 pathogenic variant; CDH1-NPVD; CDH1 no pathogenic variant detected; DGC; diffuse gastric cancer; EORTC-QOL-C30; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras
Keywords: kidney neoplasms; carcinoma; renal cell; neoplasm metastasis; molecular targeted therapy; cytokines; CCI; Charlson comorbidity index; IMDC; International Metastatic Renal Cell Carcinoma Database Consortium; MSKCC; Memorial Sloan Kettering Cancer Center; O
Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapy
Keywords: BC; breast cancer; UEH; usual epithelial hyperplasia (also called ductal hyperplasia DH); ADH; atypical ductal hyperplasia; CIS; carcinoma in situ; SRCC; signet ring cell carcinoma; FGF; fibroblast growth factor; EGFR; epidermal growth factor receptor (al
Primary Signet Ring Cell Carcinoma of the Prostate
Keywords: GI; gastrointestinal; PSA; prostate-specific antigen; PSAP; prostate-specific acid phosphatase; RARP; robot-assisted radical prostatectomy; SRCC; signet ring cell carcinoma; TURP; transurethral resection of the prostate;